Fundraising FoxAutifony Therapeutics
Stevenage, GB · 2 known investors
Find your way into Autifony Therapeutics
Sign up to find every way you can get introduced to Autifony Therapeutics
- Your email: who you already know at Autifony Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Autifony Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Autifony Therapeutics is a privately funded biopharmaceutical company developing treatments for neurological conditions including Fragile X Syndrome and orphan epilepsy syndromes.
Founders & leadership
CH
Charles H. LargeFounder and Chief Executive Officer
GA
Giuseppe AlvaroDirector
DU
Daniel Umbricht
BD
Barbara Domayne-Hayman
MG
Martin Gunthorpe
HS
Hannah Selin
AS
Alice Sharman
WK
Wendy Kennedy
Investors · 2
Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M
How we know: Pfizer Venture Investments's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Autifony Therapeutics do?
- Autifony Therapeutics is a privately funded biopharmaceutical company developing treatments for neurological conditions including Fragile X Syndrome and orphan epilepsy syndromes.
- Who founded Autifony Therapeutics?
- Autifony Therapeutics was founded by Charles H. Large.
- Who are Autifony Therapeutics's investors?
- Autifony Therapeutics's investors include Pfizer Venture Investments, SV Health Investors.
- Where is Autifony Therapeutics headquartered?
- Autifony Therapeutics is headquartered in Stevenage, GB.